Mark Allen Bach serves as Executive at Structure Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Mark Allen Bach has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 15, 2024 involved receiving (via award) 26,235 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 15, 2024 | GPCR | $0 | Award | 26,235 | $N/A | Discretionary |
Mark Allen Bach currently holds 26,235 shares of Structure Therapeutics Inc. (GPCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Allen Bach has been a net neutral trader of GPCR stock. They have purchased $0 and sold $0 worth of shares.
Mark Allen Bach's most recent insider trade was on Mar 15, 2024, when they sold 26,235 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted